Delivery Order SPE2DB22D3501-SPE2DB24FUZ81
Award Date 3/21/24
Potential Completion Date 3/22/24
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.07 firm fixed-price delivery order is for the provision of QSYMIA 7.5 MG-46 MG CAPSULE 30S, with a performance period extending through May 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,887.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QSYMIA 7.5 MG-46 MG capsules, with a performance period extending through April 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,608.40 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities...
- This federal contract award, valued at $1,525.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it covers the supply of the pharmaceutical product QSYMIA 15 MG-92 MG CAPSULE 30S. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. It is not designated as a set-aside...
- This federal contract award, with ID SPE2DX15D6028|SPE2DX25FWFHY, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,243.89 firm fixed price delivery order is for the supply of QSYMIA 3.75MG-23MG 30S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 20, 2024. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a defense...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,708.20, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of the pharmaceutical product QSYMIA 3.75MG-23MG 30S. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,130.40, for the delivery of the pharmaceutical product QSYMIA 15MG-92MG 30S. The contract has an ultimate completion date of August 11, 2025 and was awarded on July 15, 2025. The contract is not set aside and is part...
- This federal contract award is for the delivery of the prescription drug Qsymia 3.75 mg-23 mg capsules, in 30-count packages, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,544.45 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp's Corporate Office division. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of...
- This federal contract award, with a ceiling value of $2,073.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product QSYMIA 7.5 MG-46 MG CAPSULE 30S. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,945.44 firm fixed-price delivery order for QSYMIA 11.25 mg-69 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The product...